Pitney Bowes, Inc. (PBI)

NYSEIndustrialsIntegrated Freight & LogisticsSnapshot 2026-10-23

$17.35-1.08%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Pitney Bowes, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	466.21M
EPS	—	0.417
Annual ending 2026-12-31
Revenue	—	1.85B
EPS	—	1.675
Annual ending 2027-12-31
Revenue	—	1.84B
EPS	—	1.822

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Adjusted EBIT grows to at least $130 million in 2026-Q1	Operating income is rising, with adjusted EBIT up 9% year over year.	Intact	Adjusted EBIT falls below $120 million in 2026-Q1	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Adjusted EBIT increased from $102 million in Q2 2025 to $116 million in Q2 2026 and from $120 million in Q1 2025 to $130 million in Q1 2026. Cost reductions and operational improvements contributed to this growth. The trajectory is delivering consistent improvement in operating income and adjusted EBIT. Delivery assessment Oct 24, 2026
Share repurchases of at least 17 million shares in 2026-Q1	Share buybacks are strong, with 17.2 million shares repurchased in 2026-Q1.	Intact	Share repurchases fall below 15 million shares in 2026-Q1	Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. The Company reduced debt by $201 million from Q1 to Q2 2026 and repurchased 4.5 million shares for $53 million in Q2. Year-to-date through May 1, 2026, 17.2 million shares were repurchased for $186 million. In Q4 2025, principal debt was reduced by $114 million. The trajectory shows consistent delivery on capital allocation commitments. Delivery assessment Oct 24, 2026
Free cash flow of about $362.5 million in FY26	Pitney Bowes is improving cash flow, with free cash flow at $362.5 million guided for 2026.	Intact	Free cash flow falls below $330 million in FY26	Free cash flow: $128.781M FY2026-Q2; GAAP. Published target: ~$362.5 million. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026128,781,000 USD · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Cash from operations increased from $111 million in Q2 2025 to $153 million in Q2 2026, and adjusted free cash flow rose from $106 million to $148 million in the same period. Improvements reflect operational efficiencies and cost control. The trajectory is delivering positive cash flow growth. Delivery assessment Oct 24, 2026
Revenue stabilizes near $1.82 billion in FY26	A primary condition in Pitney Bowes, Inc.'s published investment case. The stated target is >= $1.8 billion.	Under Pressure	Revenue falls below $1.8 billion in FY26	Revenue: $451.498M FY2026-Q2; GAAP. Published target: >= $1.8 billion. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026451,498,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 92ccb9bf-7635-4ee4-bebb-169ad42c66a7. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Revenue declined modestly from $462 million in Q2 2025 to $451 million in Q2 2026 and from $493 million in Q1 2025 to $477 million in Q1 2026. Management notes moderated declines and improving sales trends, but revenue remains under pressure. The trajectory shows limited progress toward stabilization. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPSUnavailable

$1.75 → Unavailable · observed estimates

FY2027 revenueUnavailable

Unavailable → Unavailable · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.75	Unavailable	6 / 4
2026-07-25	$1.75	Unavailable	6 / 4
2026-07-26	$1.75	Unavailable	6 / 4
2026-07-27	$1.75	Unavailable	6 / 4
2026-07-28	$1.75	Unavailable	6 / 4
2026-07-29	$1.75	Unavailable	6 / 4
2026-07-30	$1.75	Unavailable	6 / 4
2026-07-31	Unavailable	Unavailable	4 / 3
2026-08-01	Unavailable	Unavailable	4 / 3
2026-08-02	$1.82	$1,839,624,870	6 / 5
2026-08-03	Unavailable	Unavailable	3 / 3
2026-08-04	Unavailable	Unavailable	3 / 3
2026-08-05	Unavailable	Unavailable	3 / 3
2026-08-06	$1.82	$1,836,690,270	6 / 5
2026-08-07	Unavailable	Unavailable	3 / 3
2026-08-08	$1.82	$1,836,690,270	6 / 5
2026-08-09	$1.82	$1,836,690,270	6 / 5
2026-08-10	$1.82	$1,836,690,270	6 / 5
2026-08-12	$1.82	$1,836,690,270	6 / 5
2026-08-13	Unavailable	Unavailable	3 / 3
2026-08-14	Unavailable	Unavailable	3 / 3
2026-08-15	Unavailable	Unavailable	3 / 3
2026-08-16	Unavailable	Unavailable	3 / 3
2026-08-17	Unavailable	Unavailable	3 / 3
2026-08-18	Unavailable	Unavailable	3 / 3
2026-08-19	Unavailable	Unavailable	3 / 3
2026-08-20	Unavailable	Unavailable	4 / 3
2026-08-21	Unavailable	Unavailable	4 / 3
2026-08-22	Unavailable	Unavailable	4 / 3
2026-08-23	Unavailable	Unavailable	4 / 3
2026-08-24	Unavailable	Unavailable	4 / 3
2026-08-25	Unavailable	Unavailable	4 / 3
2026-08-26	Unavailable	Unavailable	4 / 3
2026-08-27	Unavailable	Unavailable	4 / 3
2026-08-28	Unavailable	Unavailable	4 / 3
2026-08-29	Unavailable	Unavailable	4 / 3
2026-08-30	Unavailable	Unavailable	4 / 3
2026-08-31	Unavailable	Unavailable	4 / 3
2026-09-01	Unavailable	Unavailable	4 / 3
2026-09-02	Unavailable	Unavailable	4 / 3
2026-09-03	Unavailable	Unavailable	4 / 3
2026-09-04	Unavailable	Unavailable	4 / 3
2026-09-05	Unavailable	Unavailable	4 / 3
2026-09-06	Unavailable	Unavailable	4 / 3
2026-09-07	Unavailable	Unavailable	4 / 3
2026-09-08	Unavailable	Unavailable	4 / 3
2026-09-09	Unavailable	Unavailable	4 / 3
2026-09-10	Unavailable	Unavailable	4 / 3
2026-09-11	Unavailable	Unavailable	4 / 3
2026-09-12	Unavailable	Unavailable	4 / 3
2026-09-13	Unavailable	Unavailable	4 / 3
2026-09-14	Unavailable	Unavailable	4 / 3
2026-09-15	Unavailable	Unavailable	4 / 3
2026-09-16	Unavailable	Unavailable	4 / 3
2026-09-17	Unavailable	Unavailable	4 / 3
2026-09-18	Unavailable	Unavailable	4 / 3
2026-09-19	Unavailable	Unavailable	4 / 3
2026-09-20	Unavailable	Unavailable	4 / 3
2026-09-21	Unavailable	Unavailable	4 / 3
2026-09-22	Unavailable	Unavailable	4 / 3
2026-09-23	Unavailable	Unavailable	4 / 3
2026-09-24	Unavailable	Unavailable	4 / 3
2026-09-25	Unavailable	Unavailable	4 / 3
2026-09-26	Unavailable	Unavailable	4 / 3
2026-09-27	Unavailable	Unavailable	4 / 3
2026-09-28	Unavailable	Unavailable	4 / 3
2026-09-29	Unavailable	Unavailable	4 / 3
2026-09-30	Unavailable	Unavailable	4 / 3
2026-10-01	Unavailable	Unavailable	4 / 3
2026-10-02	Unavailable	Unavailable	4 / 3
2026-10-03	Unavailable	Unavailable	4 / 3
2026-10-04	Unavailable	Unavailable	4 / 3
2026-10-05	Unavailable	Unavailable	4 / 3
2026-10-06	Unavailable	Unavailable	4 / 3
2026-10-07	Unavailable	Unavailable	4 / 3
2026-10-08	Unavailable	Unavailable	4 / 3
2026-10-09	Unavailable	Unavailable	4 / 3
2026-10-10	Unavailable	Unavailable	4 / 3
2026-10-11	Unavailable	Unavailable	4 / 3
2026-10-12	Unavailable	Unavailable	4 / 3
2026-10-13	Unavailable	Unavailable	4 / 3
2026-10-14	Unavailable	Unavailable	4 / 3
2026-10-15	Unavailable	Unavailable	4 / 3
2026-10-16	Unavailable	Unavailable	4 / 3
2026-10-17	Unavailable	Unavailable	4 / 3
2026-10-18	Unavailable	Unavailable	4 / 3
2026-10-19	Unavailable	Unavailable	4 / 3
2026-10-20	Unavailable	Unavailable	4 / 3
2026-10-21	Unavailable	Unavailable	4 / 3
2026-10-22	Unavailable	Unavailable	4 / 3
2026-10-23	Unavailable	Unavailable	4 / 3
2026-10-24	Unavailable	Unavailable	4 / 3

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	1	4	1
2026-06-01	1	4	0
2026-07-01	1	4	0
2026-08-01	1	4	0
2026-09-01	1	4	0
2026-10-01	1	4	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Adjusted EBIT grows to at least $130 million in 2026-Q1Direct metric needs a verified mapping
Share repurchases of at least 17 million shares in 2026-Q1Required source inputs unavailable
Free cash flow of about $362.5 million in FY26Free cash flow: $128.781M
Revenue stabilizes near $1.82 billion in FY26Published status: Under Pressure

Next proof point

Oct 28, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-23.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Pitney Bowes, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a pressured business with a recovery-oriented long-term thesis, rather than a proven steady compounder. The thesis is in a watch state: execution has improved in some areas, while overall financial performance remains weak and risk is elevated.

What's priced into Pitney Bowes, Inc.

PBI is cheap versus peers, and the valuation evidence shows a negative expectations gap, meaning expectations appear muted. The valuation is tagged as justified, with low fragility, but that does not resolve the gap between improving adjusted earnings and still-declining revenue.

What the fundamentals likely do

Near term, revenue remains under pressure, although management says declines have moderated and sales trends are improving. Adjusted EBIT has risen year over year, and debt reduction and share repurchases are on track; however, a recent earnings beat and guidance raise do not erase the history of weak performance or the risk of a credibility setback if guidance is cut.

What Pitney Bowes, Inc. hinges on

Over the next several quarters, the key test is whether revenue stabilizes while operating improvements continue. The thesis also depends on management sustaining its recent guidance and execution, and on whether major industrial peers continue to support sector momentum or instead signal a weaker backdrop.